The role of 24-hour activity in Alzheimer's Disease
24 小时活动在阿尔茨海默病中的作用
基本信息
- 批准号:10723684
- 负责人:
- 金额:$ 12.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-15 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAdultAgeAgingAlzheimer associated neurodegenerationAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAlzheimer’s disease biomarkerAmyloid beta-ProteinAwardBehaviorBehavioralBiological MarkersBlood - brain barrier anatomyCerebrospinal FluidClinicalCognitionCognitiveCross-Sectional StudiesDataDementiaDevelopmentElderlyEnvironmentEpidemiologyFunctional disorderGoalsGrowthHippocampusHourImpaired cognitionInjuryLife StyleLightLinkLiquid substanceMagnetic Resonance ImagingMeasurementMeasuresMemoryMentored Research Scientist Development AwardMentorshipMicrovascular DysfunctionModelingNatureNerve DegenerationPathologicPathologyPathway interactionsPhasePhenotypePhysical activityPlasmaPlatelet-Derived Growth Factor beta ReceptorPositioning AttributePreventionPrevention strategyPublic HealthResearchResearch ActivityResearch DesignResearch PersonnelRisk FactorsRoleSeriesSleepStatistical MethodsStructural ModelsSumSymptomsSynapsesTheoretical modelTherapeuticTimeTrainingTraining ActivityWhite Matter HyperintensityWorkactigraphyaxon injurybrain magnetic resonance imagingcohortdementia riskimaging biomarkerimprovedin vivomagnetic resonance imaging biomarkermodifiable riskneurofilamentneurograninneuroimagingneuroimaging markerneuroinflammationneuropathologypoor sleepprogramssedentarystructural imagingtau Proteinstau-1treatment strategy
项目摘要
PROJECT SUMMARY. Alzheimer’s disease and related dementias (ADRD) has become a major public health
crisis. To date, therapeutic strategies for Alzheimer’s disease have been largely ineffective resulting in an
increased focus on identifying effective prevention strategies. Daily 24-hour activity behaviors (sleep, physical
activity, and sedentary time) may be modifiable risk factors for ADRD. A better understanding of these risk
factors may provide an opportunity for early prevention, particularly in the asymptomatic phase prior to the
development of ADRD-related pathology. The availability of longitudinal actigraphy data to objectively-measure
24-hour activity in a strongly ADRD-phenotyped cohort has created the ideal opportunity to investigate
potential pathways linking 24-hour activity behaviors with ADRD. The objective of this K01 is to longitudinally
investigate changes in 24-hour activity with changes in cognition, structural neuroimaging, and fluid biomarkers
of Alzheimer’s disease and concomitant pathological pathways prior to the onset of clinical dementia. I will
leverage data from the Vanderbilt Memory and Aging Project (VMAP) cohort with repeated measures of
actigraphy, brain MRI, and fluid biomarkers of Alzheimer’s disease neuropathology and concomitant injury. The
central hypothesis of this proposal is changes in 24-hour activity will be associated with cognitive decline,
structural neuroimaging changes, and Alzheimer’s disease and concomitant pathway changes, preceding
symptom onset. Based on this hypothesis, the proposal aims to 1) characterize associations between changes
in 24-hour activity and cognitive decline, 2) examine changes in 24-hour activity in relation to MRI markers of
neurodegeneration and small vessel disease, and 3) evaluate changes in 24-hour activity behaviors with fluid
biomarkers of Alzheimer’s disease neuropathology and concomitant pathways. Taken together, these aims will
combine objective measurement of 24-hour activity with cognitive, neuroimaging, and state of the art fluid
biomarker data to fill existing gaps in the research. Simultaneously, throughout the award, the candidate will
gain advanced training in 1) Alzheimer’s disease pathophysiology and epidemiology; 2) measurement and
modeling of structural imaging and fluid biomarkers of Alzheimer’s neuropathology and concomitant pathways
of injury; and 3) advanced statistical methods, positioning the candidate to become a leader in the fields of
aging and Alzheimer’s disease epidemiology. Vanderbilt University Medical Center and the Vanderbilt Memory
and Alzheimer’s Center provide the ideal environment to complete the proposed research and training
activities. The overall goal of this K01 is to inform a series of R01 awards and independent research program
focused on identifying and characterizing behavioral risk factors for ADRD. With the support of this K01 award
and expert mentorship, the candidate will achieve this goal and successfully transition to independent
investigator status by the conclusion of the training period.
项目摘要。阿尔茨海默氏病和相关痴呆症(ADRD)已成为主要的公共卫生
危机。迄今为止,阿尔茨海默氏病的理论策略在很大程度上无效,导致
增加专注于确定有效的预防策略。每日24小时的活动行为(睡眠,身体
活动和久坐时间)可能是ADRD的可修改风险因素。更好地理解这些风险
因素可能为早期预防提供机会,尤其是在无症状阶段
与ADRD相关的病理的发展。纵向行为摄影数据的可用性以客观衡量
24小时的活动在强烈的ADRD型人群中,为调查创造了理想的机会
将24小时活动行为与ADRD联系起来的潜在途径。该K01的目的是纵向
研究24小时活动的变化,认知,结构神经影像和流体生物标志物的变化
临床痴呆发作之前,阿尔茨海默氏病和伴随的病理途径。我会
利用范德比尔特记忆和老化项目(VMAP)队列的数据,并重复衡量
阿尔茨海默氏病神经病理学和伴随损伤的动作学,大脑MRI和液体生物标志物。
该建议的中心假设是24小时活动的变化将与认知能力下降有关,
结构性神经成像变化,阿尔茨海默氏病和伴随途径变化,此前
症状发作。基于此假设,该提案的目的是1)表征变化之间的关联
在24小时的活动和认知下降中,2)检查与24小时活动的变化相对于MRI标记
神经变性和小血管疾病,3)评估流体24小时活动行为的变化
阿尔茨海默氏病神经病理学和伴随途径的生物标志物。两者一起,这些目标将
将24小时活性的客观测量与认知,神经影像和最先进的状态相结合
生物标志物数据以填补研究中的现有空白。同时,在整个奖项中,候选人将
在1)阿尔茨海默氏病的病理生理学和流行病学中获得高级培训; 2)测量和
阿尔茨海默氏神经病理学和伴随途径的结构成像和流体生物标志物的建模
受伤; 3)高级统计方法,将候选人定位为成为领域的领导者
衰老和阿尔茨海默氏病流行病学。范德比尔特大学医学中心和范德比尔特的记忆
阿尔茨海默氏症中心提供了理想的环境,以完成拟议的研究和培训
活动。该K01的总体目标是为一系列R01奖和独立研究计划提供信息
专注于识别和表征ADRD的行为风险因素。在该K01奖的支持下
和专家精神制,候选人将实现这一目标,并成功过渡到独立
调查人员的状态通过培训期的结论。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kelsie Marie Full其他文献
Kelsie Marie Full的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Philadelphia Regional Stroke Trials Network Coordinating Center (PRSTNCC)
费城地区卒中试验网络协调中心 (PRSTNCC)
- 批准号:
10851524 - 财政年份:2023
- 资助金额:
$ 12.02万 - 项目类别:
Center for SOcial CApital (SOCA): Promoting Multigenerational Health
社会资本中心 (SOCA):促进多代健康
- 批准号:
10661344 - 财政年份:2023
- 资助金额:
$ 12.02万 - 项目类别:
Understanding the physiology and pathophysiology of kidney-derived vasopressin
了解肾源性加压素的生理学和病理生理学
- 批准号:
10644062 - 财政年份:2023
- 资助金额:
$ 12.02万 - 项目类别:
Phase 2 Study of Theophylline for the Treatment of Psuedohypoparathyroidism
茶碱治疗假性甲状旁腺功能减退症的 2 期研究
- 批准号:
10775196 - 财政年份:2023
- 资助金额:
$ 12.02万 - 项目类别: